Evidence map›Paper›PMID 42402566›Full record

ReviewBMC neurology2026

Diagnostic overshadowing in primary progressive multiple sclerosis with coexisting tethered cord syndrome and long-standing urological dysfunction: a case report and literature review.

Taleb Alsalloum, Haifa Alsamman, Rahma Alkerdi, Ghiath Alassad

Abstract readCase ReportsReview
In one paragraph

Review in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Taleb AlsalloumFaculty of Medicine, University of Hama, Hama, Syria. talepalsalom@gmail.com.ORCID https://orcid.org/0000-0001-9692-570X
Haifa AlsammanNeurology Department, Hama National Hospital, Hama, Syria.
Rahma AlkerdiFaculty of Medicine, University of Hama, Hama, Syria.
Ghiath AlassadNeurology Department, Hama National Hospital, Hama, Syria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary progressive multiple sclerosis (PPMS) may be diagnostically challenging when coexisting structural spinal abnormalities produce overlapping neurological and urinary manifestations. Tethered cord syndrome (TCS) and PPMS can both present with progressive myelopathy and lower urinary tract symptoms, increasing the risk of diagnostic overshadowing. CASE PRESENTATION: A 42-year-old woman with a history of sacrococcygeal meningocele and prior surgical resection presented with a 20-year history of urinary dysfunction and a 2-year history of progressive ascending sensory symptoms and mild paraparesis. Her symptoms had initially been attributed to her structural and surgical history. However, neurological examination, brain and whole-spine MRI, and CSF analysis demonstrated characteristic demyelinating lesions and positive oligoclonal bands. She fulfilled the 2024 McDonald criteria for PPMS. Because ocrelizumab was unavailable locally, rituximab was initiated as an off-label alternative.

conclusionThis case highlights the importance of considering a concurrent neuroinflammatory disorder in patients with pre-existing structural spinal pathology and chronic urinary dysfunction. Careful integration of clinical, radiological, and CSF findings is essential to avoid diagnostic delay in complex dual-pathology presentations.

Indexed as

Multiple Sclerosis, Chronic ProgressiveNeural Tube DefectsUrologic DiseasesAdultFemaleHumansMagnetic Resonance ImagingDiagnostic overshadowingPrimary progressive multiple sclerosisRituximabSpinal dysraphismTethered cord syndrome

Identifiers

PMID42402566
PMCPMC13613749

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.